Pharmacotherapy for the management of overweight and obesity.

IF 1.6 4区 医学 Q2 MEDICINE, GENERAL & INTERNAL
Patrice Forner, Samantha Hocking
{"title":"Pharmacotherapy for the management of overweight and obesity.","authors":"Patrice Forner, Samantha Hocking","doi":"10.31128/AJGP-09-24-7411","DOIUrl":null,"url":null,"abstract":"<p><strong>Background: </strong>Lifestyle intervention is the mainstay of obesity management; however, behavioural modification alone produces only modest results and attempts to create a negative energy balance are offset by a biological response to maintain weight. Pharmacotherapy is indicated as an adjunct for those living with obesity (body mass index [BMI] ≥30 kg/m2) or those who are overweight (BMI ≥27 kg/m2) with a least one weight-related complication.</p><p><strong>Objective: </strong>This article provides an update on pharmacotherapy for the management of overweight and obesity.</p><p><strong>Discussion: </strong>Pharmacotherapy is a useful adjunct for the treatment of obesity and obesity-related comorbidities. When considering pharmacotherapy, thought must be given to efficacy, contraindications, potential side effects, cost and duration of treatment.</p>","PeriodicalId":54241,"journal":{"name":"Australian Journal of General Practice","volume":"54 4","pages":"196-201"},"PeriodicalIF":1.6000,"publicationDate":"2025-04-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Australian Journal of General Practice","FirstCategoryId":"3","ListUrlMain":"https://doi.org/10.31128/AJGP-09-24-7411","RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q2","JCRName":"MEDICINE, GENERAL & INTERNAL","Score":null,"Total":0}
引用次数: 0

Abstract

Background: Lifestyle intervention is the mainstay of obesity management; however, behavioural modification alone produces only modest results and attempts to create a negative energy balance are offset by a biological response to maintain weight. Pharmacotherapy is indicated as an adjunct for those living with obesity (body mass index [BMI] ≥30 kg/m2) or those who are overweight (BMI ≥27 kg/m2) with a least one weight-related complication.

Objective: This article provides an update on pharmacotherapy for the management of overweight and obesity.

Discussion: Pharmacotherapy is a useful adjunct for the treatment of obesity and obesity-related comorbidities. When considering pharmacotherapy, thought must be given to efficacy, contraindications, potential side effects, cost and duration of treatment.

背景:生活方式干预是肥胖症治疗的主要方法;然而,仅靠行为矫正只能产生适度的效果,试图建立负能量平衡的努力会被维持体重的生物反应所抵消。药物疗法适用于肥胖症患者(体重指数[BMI]≥30 kg/m2)或超重患者(体重指数≥27 kg/m2)以及至少一种体重相关并发症患者的辅助治疗:本文介绍了药物疗法治疗超重和肥胖症的最新进展:讨论:药物疗法是治疗肥胖和肥胖相关并发症的有效辅助手段。在考虑药物疗法时,必须考虑到疗效、禁忌症、潜在副作用、费用和疗程。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
求助全文
约1分钟内获得全文 求助全文
来源期刊
Australian Journal of General Practice
Australian Journal of General Practice Medicine-Family Practice
CiteScore
2.80
自引率
4.50%
发文量
284
期刊介绍: The Australian Journal of General Practice (AJGP) aims to provide relevant, evidence-based, clearly articulated information to Australian general practitioners (GPs) to assist them in providing the highest quality patient care, applicable to the varied geographic and social contexts in which GPs work and to all GP roles as clinician, researcher, educator, practice team member and opinion leader. All articles are subject to peer review before they are accepted for publication.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
确定
请完成安全验证×
copy
已复制链接
快去分享给好友吧!
我知道了
右上角分享
点击右上角分享
0
联系我们:info@booksci.cn Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。 Copyright © 2023 布克学术 All rights reserved.
京ICP备2023020795号-1
ghs 京公网安备 11010802042870号
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术官方微信